AEF0217 - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Continental Resources is expanding its Permian Basin footprint through the acquisition of FireBird Energy II, adding about 54,000 net Midland Basin acres and 32,000 barrels of oil equivalent per day of production, including a 69% oil mix. Representative image.

Continental Resources to buy FireBird as Permian footprint grows more than 40%

Mitsubishi Electric Corporation’s $1.4 billion acquisition of PCI Energy Solutions expands its push into power-market software as utilities manage increasingly complex grids shaped by renewables, battery storage and rising electricity demand. Representative image.

Mitsubishi Electric’s $1.4bn PCI deal targets software managing 60% of US power

Johan Sverdrup crude could meet 25% of ORLEN demand under three-year agreement

Equinor strikes three-year ORLEN deal for up to 9m tonnes of crude a year

APA Group is advancing the A$259 million Sybella Creek Solar Farm and Battery Energy Storage System in Mount Isa, combining 72 MW of solar generation with a 52 MW/104 MWh battery and existing gas-fired power infrastructure under a long-term supply agreement with Ernest Henry Mining. Representative image.

APA Group (ASX: APA) commits A$259m to Mount Isa solar and battery project

Representative image of a clinical trial setting highlighting Aelis Farma’s Phase 2B AEF0217 study targeting cognitive and behavioral impairments in Down syndrome patients across Europe.

Read More

Pharma Industry News

Aelis Farma’s AEF0217 enters critical Phase 2B trial—can it become the first drug for Down syndrome cognition?

Aelis Farma launches Phase 2B trial for AEF0217 in Down syndrome—could this CB1-targeting drug finally deliver a breakthrough? Read more.

March 22, 2026

web analytics